BioCorRx Inc. (BICX) financial statements (2022 and earlier)

Company profile

Business Address 2390 EAST ORANGEWOOD AVENUE
ANAHEIM, CA 92806
State of Incorp.
Fiscal Year End December 31
SIC 8093 - Specialty Outpatient Facilities, Not Elsewhere Classified (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)
Annual | Quarterly

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1300000
Cash and cash equivalents1300000
Restricted cash and investments   0   
Prepaid expense0000000
Other current assets      4
Other undisclosed current assets0000 0(4)
Total current assets:1300000
Noncurrent Assets
Operating lease, right-of-use asset00✕✕✕✕✕
Property, plant and equipment0000000
Long-term investments and receivables0000000
Long-term investments0000000
Intangible assets, net (including goodwill)0000  4
Intangible assets, net (excluding goodwill)0000  4
Prepaid expense     00
Other undisclosed noncurrent assets000 01 
Total noncurrent assets:1100014
TOTAL ASSETS:2410014
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2221111
Accounts payable1111   
Accrued liabilities   000 
Interest and dividends payable1110   
Settlement liabilities   00  
Other undisclosed accounts payable and accrued liabilities000(0)111
Deferred revenue00✕✕✕✕✕
Debt (0)1 010
Derivative instruments and hedges, liabilities    00 
Due to related parties 00000 
Deferred revenue and credits✕✕✕0011
Other undisclosed current liabilities0040000
Total current liabilities:3362242
Noncurrent Liabilities
Long-term debt and lease obligation00    0
Long-term debt, excluding current maturities      0
Operating lease, liability00✕✕✕✕✕
Liabilities, other than long-term debt, including:0003612
Deferred revenue and credits✕✕✕0111
Deferred revenue00✕✕✕✕✕
Derivative instruments and hedges, liabilities    50 
Other undisclosed liabilities, other than long-term debt  02101
Other undisclosed noncurrent liabilities22    (0)
Total noncurrent liabilities:3203612
Total liabilities:6564954
Stockholders' equity
Stockholders' equity attributable to parent, including:(4)(1)(6)(4)(8)(3)0
Preferred stock  00000
Common stock0000000
Common stock, value, subscriptions000000 
Additional paid in capital6060494511109
Accumulated deficit(65)(61)(55)(49)(19)(13)(9)
Other undisclosed stockholders' equity attributable to parent(0)(0)(0)00 0
Stockholders' equity attributable to noncontrolling interest(0)(0)     
Other undisclosed stockholders' equity000    
Total stockholders' equity:(4)(1)(6)(4)(8)(3)0
Other undisclosed liabilities and equity(0)(0)(0)    
TOTAL LIABILITIES AND EQUITY:2410014

Income statement (P&L) ($ in millions)
Annual | Quarterly

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues0001111
Revenue, net✕✕✕1111
Cost of revenue(0)(0)(0)(0)(0)(0)(0)
Cost of goods and services sold    (3)  
Gross profit:0000111
Operating expenses(8)(6)(5)(4)(3)(6)(4)
Other undisclosed operating income000000 
Operating loss:(7)(6)(5)(3)(2)(5)(3)
Nonoperating income (expense)4(0)(2)(27)(4)0 
Interest and debt expense(0)(0)00(0)1(0)
Loss from continuing operations before income taxes:(4)(6)(7)(29)(6)(4)(4)
Income tax expense(0)      
Other undisclosed income from continuing operations4      
Net income (loss):0(6)(7)(29)(6)(4)(4)
Net income attributable to noncontrolling interest367    
Other undisclosed net income (loss) attributable to parent(7)(6)(7)(0)0(1) 
Net loss available to common stockholders, diluted:(4)(6)(7)(30)(6)(5)(4)

Comprehensive Income ($ in millions)
Annual | Quarterly

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):0(6)(7)(29)(6)(4)(4)
Comprehensive income (loss):0(6)(7)(29)(6)(4)(4)
Comprehensive income, net of tax, attributable to noncontrolling interest367    
Comprehensive income (loss), net of tax, attributable to parent:4(0)(0)(29)(6)(4)(4)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: